|
|
|
|
|
|
Integrating this assay into product release testing enhances patient safety by providing a rapid and reliable method to detect rcAAVs during commercial production.
|
|
|
|
|
Addressing the risks associated with replication-competent lentiviruses (RCLs) is essential to ensure the safe and effective application of lentiviral vectors in advanced therapeutic interventions.
|
|
|
|
|
In this webinar, speakers explore key innovations in plasmid design and production, highlighting how these advancements can directly enhance biomanufacturing workflows.
|
|
|
|
|
Gain insights into the significance of plasmid design in viral vector production, the value of establishing a Plasmid Master Cell Bank (MCB), and the use of analytical assays and Next-Generation Sequencing (NGS) for plasmid verification.
|
|
|
|
|
Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.
|
|
|
|
|
We're dedicated to solving your manufacturing challenges efficiently. Our services include high-throughput drug substance production, drug product manufacturing suites, integrated testing, and plasmid production.
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical companies must urgently secure a reliable nitrosamine testing partner by August 2025 to ensure compliance with FDA guidelines. Inaccurate testing could result in regulatory non-compliance.
|
|
|
|
|
Review real-world examples highlighting the numerous advantages of SMB technology, including rapid development timelines, seamless scalability, and compliance with cGMP standards for API manufacturing.
|
|
|
|
|
Discover how Simulated Moving Bed (SMB) technology can revolutionize your purification processes by enhancing efficiency, reducing costs, and promoting sustainable practices.
|
|
|
|
|
We specialize in the custom development and manufacturing of small molecule APIs, intermediates, and RSMs, offering scalable solutions from kilograms to multi-ton quantities.
|
|
|
|
|
Explore how advanced high-potency capabilities and specialized expertise are driving the development and manufacturing of next-generation ADC payloads and linkers.
|
|
|
